DoctorsProofNPPES directory · verify at state boards

Cardiovascular Disease in Merriam, KS

7 verified cardiovascular disease doctors in Merriam.

Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Kansas Board of Healing Arts

Dr. Anthony Albracht, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1841299112
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,308 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,308

Total received

58

Transactions

23

Paying companies

Top paying companies

Boston Scientific Corporation$191.58
Amgen Inc.$184.64
ABIOMED$151.94
Merck Sharp & Dohme LLC$75.89
NOVARTIS PHARMACEUTICALS CORPORATION$70.65
Pfizer Inc.$67.78

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 77th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Anthony Albracht do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Thaju Salam, MD

Cardiovascular Disease

20 yrs NPPES
NPI 1295794733
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,510 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,510

Total received

75

Transactions

17

Paying companies

Top paying companies

Boston Scientific Corporation$375.90
Novo Nordisk Inc$232.35
Pfizer Inc.$133.12
Amgen Inc.$121.73
sanofi-aventis U.S. LLC$102.76
Merck Sharp & Dohme LLC$93.77

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Thaju Salam do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Michelle Dew, MD

Cardiovascular Disease

20 yrs NPPES
NPI 1003853763
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $475.59 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$475.59

Total received

10

Transactions

7

Paying companies

Top paying companies

Boston Scientific Corporation$211.70
Amgen Inc.$125.64
Merck Sharp & Dohme LLC$54.44
Novo Nordisk Inc$32.27
E.R. Squibb & Sons, L.L.C.$19.54
Takeda Pharmaceuticals U.S.A., Inc.$16.99

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 63th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Michelle Dew do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Matthew Earnest, MD

Cardiovascular Disease

19 yrs NPPES
NPI 1730246992
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,003 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,003

Total received

50

Transactions

20

Paying companies

Top paying companies

Amgen Inc.$201.76
Novo Nordisk Inc$145.37
Abbott Laboratories$139.91
Pfizer Inc.$104.06
NOVARTIS PHARMACEUTICALS CORPORATION$47.62
Kiniksa Pharmaceuticals, Ltd.$42.22

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 73th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Matthew Earnest do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mazda Biria, MD

Cardiovascular Disease

19 yrs NPPES
NPI 1194847244
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,386 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,386

Total received

60

Transactions

19

Paying companies

Top paying companies

Biosense Webster, Inc.$529.19
Novo Nordisk Inc$170.77
sanofi-aventis U.S. LLC$105.66
Abbott Laboratories$91.81
CARDIVA MEDICAL, INC.$72.67
Pfizer Inc.$68.90

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 78th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Mazda Biria do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Andrew Waters, MD

Cardiovascular Disease

15 yrs NPPES
NPI 1538456025
9119 W 74TH ST STE 350, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $3,218 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,218

Total received

103

Transactions

24

Paying companies

Top paying companies

Abbott Laboratories$1,497
Boston Scientific Corporation$227.39
Merck Sharp & Dohme LLC$198.70
NOVARTIS PHARMACEUTICALS CORPORATION$159.91
Boehringer Ingelheim Pharmaceuticals, Inc.$158.31
E.R. Squibb & Sons, L.L.C.$123.65

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Andrew Waters do not imply any wrongdoing. Many are meals, education, or research support.

Dr. John Lecluyse, MD

Cardiovascular Disease

10 yrs NPPES
NPI 1356790810
9100 W 74TH ST, Merriam, KS 66204(913) 632-9400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $772.32 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$772.32

Total received

29

Transactions

17

Paying companies

Top paying companies

Amgen Inc.$185.13
Boston Scientific Corporation$138.65
CARDIVA MEDICAL, INC.$72.67
E.R. Squibb & Sons, L.L.C.$49.47
Daiichi Sankyo Inc.$49.03
Novo Nordisk Inc$42.68

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to John Lecluyse do not imply any wrongdoing. Many are meals, education, or research support.

Cardiovascular Disease in Merriam, KS — Verified | DoctorsProof | DoctorsProof